PMC:7319919 / 959-1150 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":37,"end":45},"obj":"Disease"},{"id":"T18","span":{"begin":46,"end":55},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"We report the case of a patient with COVID-19 pneumonia who received imatinib due to clinical deterioration despite dual therapy with hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T12","span":{"begin":22,"end":23},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"We report the case of a patient with COVID-19 pneumonia who received imatinib due to clinical deterioration despite dual therapy with hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":69,"end":77},"obj":"Chemical"},{"id":"T8","span":{"begin":134,"end":152},"obj":"Chemical"},{"id":"T9","span":{"begin":163,"end":182},"obj":"Chemical"},{"id":"T10","span":{"begin":163,"end":172},"obj":"Chemical"},{"id":"T11","span":{"begin":173,"end":182},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_45783"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"}],"text":"We report the case of a patient with COVID-19 pneumonia who received imatinib due to clinical deterioration despite dual therapy with hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"28","span":{"begin":24,"end":31},"obj":"Species"},{"id":"31","span":{"begin":69,"end":77},"obj":"Chemical"},{"id":"32","span":{"begin":134,"end":152},"obj":"Chemical"},{"id":"33","span":{"begin":154,"end":157},"obj":"Chemical"},{"id":"34","span":{"begin":163,"end":182},"obj":"Chemical"},{"id":"35","span":{"begin":184,"end":189},"obj":"Chemical"},{"id":"45","span":{"begin":37,"end":55},"obj":"Disease"}],"attributes":[{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"Tax:9606"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D000068877"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:D006886"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:D006886"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:C558899"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:C558899"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We report the case of a patient with COVID-19 pneumonia who received imatinib due to clinical deterioration despite dual therapy with hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T5","span":{"begin":46,"end":55},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"We report the case of a patient with COVID-19 pneumonia who received imatinib due to clinical deterioration despite dual therapy with hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":0,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We report the case of a patient with COVID-19 pneumonia who received imatinib due to clinical deterioration despite dual therapy with hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T16","span":{"begin":37,"end":45},"obj":"SP_7"},{"id":"T17","span":{"begin":69,"end":77},"obj":"CHEBI:45783;CHEBI:45783"},{"id":"T18","span":{"begin":134,"end":152},"obj":"CHEBI:5801;CHEBI:5801;DG_20"},{"id":"T19","span":{"begin":163,"end":172},"obj":"DG_23"},{"id":"T20","span":{"begin":173,"end":182},"obj":"DG_30"},{"id":"T35262","span":{"begin":37,"end":45},"obj":"SP_7"},{"id":"T96047","span":{"begin":69,"end":77},"obj":"CHEBI:45783;CHEBI:45783"},{"id":"T20501","span":{"begin":134,"end":152},"obj":"CHEBI:5801;CHEBI:5801;DG_20"},{"id":"T65802","span":{"begin":163,"end":172},"obj":"DG_23"},{"id":"T69496","span":{"begin":173,"end":182},"obj":"DG_30"}],"text":"We report the case of a patient with COVID-19 pneumonia who received imatinib due to clinical deterioration despite dual therapy with hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r)."}